| HOME | PRODUCTS & SERVICES | ORDER/INQUIRY | PRESS RELEASES | EMPLOYMENT | CONTACT US |
FUTURE ONCOLOGY
Volume 5 #4/5 August/September 1999
State-of-the-Art in the Management of Cancer
LUNG CANCER-PART II
SCREENING, DIAGNOSIS, AND CLASSIFICATION
Lung Cancer Screening
Chest X-ray
Low-dose Helical Computed Tomography (CT)Sputum Cytology
Breath Analysis
Molecular Markers
Presentation and Diagnosis
Brush Cytology
Endoscopy/Bronchoscopy
Biopsy
Noninvasive Imaging
- Computed Tomography (CT)
- Nuclear Medicine
Histology and Classification
Special Review
ONCOLOGY TRENDS
PRODUCT MARKETS-PART II
Hormone Modulating Drugs
Antiestrogens
- Tamoxifene
- Raloxifene
- Toremifene
Aromatase Inhibitors
- Anastozole
- Exemestane
- Fadrozole
- Formestane
- Letrozole
Antiandrogens
- Bicalutamide
- Cyproterone acetate
- Flutamide
- Goserelin
- Leuprolide acetate
- Nilutamide
Other Chemotherapeutics
Alitretinoin
Anthracyclines
- Daunorubicin
- Epirubicin
- Liposomal daunorubicin
- Liposomal doxorubicin
- Mitoxantrone
- Valrubicin
Busulfan
Carmustine Wafer
Etoposide Phosphate
FlutarabineGemcitabine
Liposomal Cytarabine
Methoxsalen
Porfimer Sodium
Temozolomide
Biologicals
Aldesleukin
Denileukin Diftitox
Interferon a
- Interferon a -2a
- Interferon a -2b
Rituximab
Trastuzumab
Adjunct Therapies
Amofistene
Colony Stimulating Factors
- Filgrastim
- Lenograstim
- Sargramostim
Octreotide Acetate
Oprelvekin
Pamidronate Disodium